Do you sometimes have difficulty affording your medication?
No insurance required. All patients are eligible.*
For FREE delivery options, see FAQ section for details.
Administered by: Truax Patient Services | Bemidji, MN 56601
Please see full Prescribing Information, including Boxed Warning for ADTHYZA®.
Please see full Prescribing Information, including Boxed Warning for EDARBI® and EDARBYCLOR®.
Please see product Important Safety Information below.
You or your doctor sends the prescription to Truax Patient Services
You can call 844-289-3981 to inquire about your prescription
Medication is delivered directly to your door
No insurance required. All patients are eligible.*
| BRAND | MEDICATION SUPPLY | OPT-OUT-OF-POCKET COSTS FOR STANDARD DOSAGES |
|---|---|---|
| ADTHYZA® | 30 DAYS 90 DAYS |
$35 plus shipping $90 FREE SHIPPING |
| EDARBI® and EDARBYCLOR® | 30 DAYS 90 DAYS |
$50 plus shipping $150 FREE SHIPPING |
| BiDil® | 30 DAYS 90 DAYS |
$40 plus shipping $150 FREE SHIPPING |
| HORIZANT® | 30 DAYS 90 DAYS |
$55 plus shipping $165 FREE SHIPPING |
Azurity Solutions – Patient Direct provides an auto-refill option.
Home delivery saves you time.
*The cash discount prices listed are not valid for use with any prescription drug benefit plan. Azurity Solutions - Patient Direct applies only to eligible products from Azurity Pharmaceuticals, Inc.
You or your health care provider will send your prescription to be processed by the Azurity Solutions – Patient Direct partner organization, Truax Patient Services. You’ll pay guaranteed cash pricing for your listed Azurity product prescriptions. See pricing above.
Free delivery options are applicable only on the following products:
Azurity Solutions – Patient Direct offers a simple, 1-step enrollment process to save money on prescription medications that are conveniently delivered directly to you.
Azurity Solutions – Patient Direct is a cash-payment only program, available for all patients, including uninsured patients and patients 65 years of age and older, who are not utilizing a Medicare benefit. Azurity Solutions – Patient Direct does not accept insurance including Medicare Part-D, Medicaid, any other Federal insurance programs or private insurance. Please complete the free enrollment accordingly.
There are 2 easy steps: 1) You or your health care provider sends your prescription to Truax Patient Services electronically, by mail, or via fax. 2) Your medication is delivered to your door. You can call 844-289-3981 to inquire about your prescription.
To submit a prescription, your health care provider may choose one of the following options:
E-prescription
Truax Patient Services
Bemidji, MN 56601
NCPDP# 2431461
NPI# 1700149096
Surescripts# 169851
Truax Patient Services is the Azurity Solutions – Patient Direct trusted pharmacy administrator, staffed by registered pharmacists and certified pharmacy technicians.
No, Azurity Solutions – Patient Direct is a cash-only program, which allows for direct cash discounts to patients.
No, Azurity Solutions – Patient Direct is a cash-only program, which allows for direct cash discounts to patients.
Yes. Insurance is not required to participate in Azurity Solutions – Patient Direct.
Once we receive the prescription, your order will be processed and handled by the registered pharmacists and certified pharmacy technicians at Truax Patient Services. Your medication will be shipped directly to your home as soon as order processing is complete. This typically takes no longer than 7-10 business days. Standard shipping costs may apply.
With the initial order, you should receive your medication 7-10 days after enrolling in Azurity Solutions – Patient Direct as long as no order issues exist. For a refill, your order should ship within 1-2 business days after it has been processed.
The easiest way is to sign up to have your prescription refilled automatically. During the processing of your first prescription, you can let the Truax Patient Services representative know you would like the auto-refill option. Truax will call your health care provider for the refill prescription, if refills are required. If you do not initially indicate that you want your prescription refilled automatically, a form will arrive with your first order for you to fill out, sign, and return for the auto-refill option.
When you choose automatic refills, your medication refill will be processed automatically according to how the prescription is written. If a prescription is required, Truax will call your health care provider for the refill prescription. Your medication will be automatically shipped to your home and your credit card on file will be charged. You may cancel this service at any time.
Once your order has been processed, you cannot cancel your order.
Medications cannot be returned for a refund. Medications returned to Truax Patient Services are not eligible for credit.
For an additional fee, Truax Patient Services can expedite your shipment.
The Azurity Solutions – Patient Direct preferred method of payment is by credit card. The program accepts Visa, MasterCard, American Express and Discover. Personal checks and money orders are accepted, alternatively.
Truax Patient Services complies with patient privacy regulations and requirements set by the Health Insurance Portability and Accountability Act (HIPAA) in all aspects of their business. Their staff is thoroughly trained on HIPAA, and there is strict monitoring in place to safeguard your confidential information. There is a privacy policy available at customer request.
ADTHYZA® (thyroid tablets, USP) is a prescription medicine indicated as replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis.
ADTHYZA® is also indicated as a pituitary TSH suppressant in the treatment or prevention of various types of euthyroid goiters, including thyroid nodules, subacute or chronic lymphocytic thyroiditis (Hashimoto’s), multinodular goiter, and in the management of thyroid cancer.
WARNING: DRUGS WITH THYROID HORMONE ACTIVITY, ALONE OR TOGETHER WITH OTHER THERAPEUTIC AGENTS, HAVE BEEN USED FOR THE TREATMENT OF OBESITY. IN EUTHYROID PATIENTS, DOSES WITHIN THE RANGE OF DAILY HORMONAL REQUIREMENTS ARE INEFFECTIVE FOR WEIGHT REDUCTION. LARGER DOSES MAY PRODUCE SERIOUS OR EVEN LIFE-THREATENING MANIFESTATIONS OF TOXICITY, PARTICULARLY WHEN GIVEN IN ASSOCIATION WITH SYMPATHOMIMETIC AMINES SUCH AS THOSE USED FOR THEIR ANORECTIC EFFECTS.
Do not use ADTHYZA in patients with uncorrected adrenal cortical insufficiency, untreated thyrotoxicosis (high thyroid hormone levels), and apparent hypersensitivity to any component of the product.
The use of thyroid hormones for weight loss, alone or combined with other drugs, is unjustified and has been shown to be ineffective. Neither is their use justified for the treatment of male or female infertility unless this condition is accompanied by low thyroid levels.
Thyroid hormones should be used with great caution in circumstances where the integrity of the cardiovascular system is suspected. In the elderly and in patients with cardiovascular disease, ADTHYZA should be used with greater caution.
Tell your doctor about any other medical conditions you may have, especially heart disease, diabetes, blood clotting problems, and adrenal or pituitary gland problems. The dose of other drugs you may be taking to control these conditions may have to be changed while you are taking.
A reportedly apparent association between prolonged thyroid therapy and breast cancer has not been confirmed, and patients on thyroid for established indications should not discontinue therapy. No confirmatory long-term studies in animals have been performed to evaluate cancer causing potential, mutagenicity, or impairment of fertility in either males or females.
Thyroid replacement therapy for hypothyroid women should not be discontinued during pregnancy, and hypothyroidism diagnosed during pregnancy should be promptly treated. Minimal amounts of thyroid hormones are excreted in human milk. However, caution should be exercised when thyroid is administered to a nursing woman. Routine determinations of serum T4 and/or TSH are strongly advised in neonates in view of the deleterious effects of thyroid deficiency on growth and development.
Tell your doctor immediately if you experience chest pain, increased pulse rate, rapid, strong, irregular heartbeat, excessive sweating, or any other unusual event.
Partial loss of hair may be experienced by children in the first few months of thyroid therapy, but this is usually a transient phenomenon.
Many drugs and some laboratory tests may alter your therapeutic response to ADTHYZA.
Tell your doctor about all medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. Especially tell your doctor if you take medicines to treat and prevent blood clots (anticoagulants), antidiabetic agents, or oral contraceptives.
For further information, please see the accompanying complete Prescribing Information for ADTHYZA.
To report SUSPECTED ADVERSE REACTIONS, contact Azurity Pharmaceuticals, Inc. at 1‐800‐461‐7449 or the FDA at www.fda.gov/medwatch or call 1‐800‐FDA‐1088.
EDARBI and EDARBYCLOR are prescription medicines used to treat high blood pressure (hypertension). Your doctor may prescribe other medicines for you to take along with EDARBI or EDARBYCLOR to treat your high blood pressure. EDARBYCLOR is used when
one medicine is not enough or as the first medicine if your doctor decides you are likely to need more than one medicine. Medicines that lower your blood pressure may lower your chances of having a stroke or heart attack, but they don't work alone. It should be part of a complete treatment plan.
WARNING: EDARBI and EDARBYCLOR can cause harm or death to your unborn baby. If you become pregnant while taking EDARBI or EDARBYCLOR, tell your doctor right away. If you plan to become pregnant, talk to your doctor about other treatments to lower blood pressure.
You are encouraged to report side effects of prescription drugs to Azurity Pharmaceuticals, Inc., Medical Information at 1-800-461-7449 or to the FDA at www.fda.gov/medwatch or call 1‐800‐FDA‐1088.
Please talk to your healthcare professional and see complete Prescribing Information for EDARBI and EDARBYCLOR.
BiDil is approved for use with other heart medicines to treat heart failure in black patients to improve survival, improve heart failure symptoms, and help patients stay out of the hospital longer. There is little experience in patients with heart failure who experience significant symptoms while at rest. Most patients in the clinical study of BiDil also received other heart failure medicines.
Tell your doctor about any allergies you have, especially if you're sensitive to nitrates, such as nitroglycerin tablets or isosorbide dinitrate (Isordil®). BiDil has a nitrate component, so you need to let your doctor know.
Tell your doctor if you're taking any erectile dysfunction or pulmonary hypertension drugs like Viagra® or Revatio™ (sildenafil), Levitra® (vardenafil) or Cialis® (tadalafil).
Also tell your doctor if you are taking any medication to decrease blood pressure because when taken with BiDil, blood pressure may become too low.
It is possible you'll get headaches, especially at first, but they often lessen over time. Keep your doctor posted on your headache progress; he or she may want to adjust your dosage.
If you experience dizziness, call your doctor. Please make sure to tell your doctor about any of the signs or symptoms mentioned below or about any unusual events that worry you.
Drinking less fluids than your doctor recommends or losing fluid due to diarrhea, sweating, or vomiting may cause low blood pressure, lightheadedness, or fainting. If fainting occurs, stop taking BiDil and contact your doctor immediately.
Lightheadedness may occur when standing, especially after sitting or lying down.
If you experience any achy and/or swollen joints, unexplained fever for more than a few days, skin rashes, chest pain, prolonged weakness or fatigue (even after a good night's sleep), or any other unexplained signs or symptoms, make sure to tell your doctor as they may be signs of a serious medical condition.
You may also experience rapid heartbeat that could lead to chest pain or aggravate chest pain, or numbness or tingling in the hands or feet.
Headache and dizziness were the most frequent side effects experienced in studies with BiDil.
Should read: You are encouraged to report side effects of prescription drugs to Azurity Pharmaceuticals, Inc., Medical Information at 1-800-461-7449 or to the FDA at www.fda.gov/medwatch or call 1‐800‐FDA‐1088.
Please see full Prescribing Information for BiDil. This information does not take the place of talking with your healthcare provider about your condition or your treatment. Ask your doctor if BiDil may be right for you.
HORIZANT® (gabapentin enacarbil) is a prescription medicine used to:
You are encouraged to report side effects of prescription drugs by contacting Azurity Pharmaceuticals, Inc. at 1-800-461-7449 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
For more information, ask your healthcare provider or pharmacist, or consult the full Prescribing Information [Horizant.com].
Serving Overlooked Patients
The information you supply will be provided to Truax Patient Services, a company administering Azurity Solutions – Patient Direct on behalf of Azurity Pharmaceuticals, Inc. for the purpose of fulfilling your prescription. Personal health information will not be rented or sold and will be secured. Truax Patient Services may use this information to contact your healthcare provider or insurance provider for information relevant to this request.
Edarbi or Edarbyclor is exclusively marketed in the United States by Azurity Pharmaceuticals, Inc.
Edarbi and Edarbyclor are trademarks of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Azurity Pharmaceuticals, Inc.
BiDil and HORIZANT are each registered trademarks of Azurity Pharmaceuticals, Inc.
Trademarks are the property of their respective owners.
This site is intended for use by U.S. residents only.
© 2023 Azurity Pharmaceuticals, Inc.
Download full Prescribing Information for Adthyza®, Edarbi®, Edarbyclor®, BiDil® and HORIZANT®
PP-AZS-US-0011